4.7 Article

Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities

Journal

EUROPEAN JOURNAL OF CANCER
Volume 49, Issue 9, Pages 2179-2186

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2013.01.018

Keywords

HPV; Screening; Triage; Cervical disease

Categories

Funding

  1. Cancer Research UK [C569/A10404, C8162/A10406]
  2. Qiagen
  3. Gen-Probe Incorporated
  4. Abbott Molecular
  5. BD Diagnostics
  6. NorChip
  7. mtm laboratories
  8. Roche Diagnostics
  9. Genera
  10. BD Diagnostics Roche Diagnostics
  11. Ventana
  12. Hologic
  13. Merck

Ask authors/readers for more resources

Aim: To compare triage strategies using different human papillomavirus (HPV) consensus and genotyping tests and a p16(INK4a) test. Methods: 1228 women referred with a borderline or single mildly dyskaryotic smear. Samples were taken at colposcopy using PreservCyt. Tests included Hybrid Capture 2, Abbott Real-Time PCR, BD HPV, CobasW 4800, PreTect HPV-Proofer, APTIMA and p16(INK4a). Results were based on the worst histology within 9 months. Results: 97/1228 (7.9%) women had CIN3+ (203/1228 (17%) CIN2+). HPV testing alone using Hybrid Capture 2, Abbott RealTime PCR, BD HPV, Cobas 4800 or APTIMA had a sensitivity for CIN3+ ranging from 99.0% to 100.0% and specificity for

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available